B. Ramamurthy
Corporate Officer/Principal bei American Chemical Society
Profil
B.
Ramamurthy is a Member at American Chemical Society.
Previously, he worked as the President-Research & Development at Dr. Datsons Labs Ltd.
and as the Senior Vice President-Research & Development at the same company from 2008 to 2009.
He holds a doctorate from the Indian Institute of Science and undergraduate and graduate degrees from the University of Mumbai.
Aktive Positionen von B. Ramamurthy
| Unternehmen | Position | Beginn |
|---|---|---|
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | 20.06.2011 |
Ehemalige bekannte Positionen von B. Ramamurthy
| Unternehmen | Position | Ende |
|---|---|---|
| DR DATSONS LABS LTD | Technik-/Wissenschafts-/F&E-Leiter | 15.10.2009 |
| DR DATSONS LABS LTD | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von B. Ramamurthy
| Indian Institute of Science | Doctorate Degree |
| University of Mumbai | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
Dr.Datsons Labs Ltd.
 Dr.Datsons Labs Ltd. Pharmaceuticals: MajorHealth Technology Dr. Datsons Labs Ltd. engages in the manufacture, and market of contract research and manufacturing services (CRAMS), and active pharmaceutical ingredients (API). It operates through the following segments: Active Pharmaceutical Ingredients (API), Formulation, and Trading. The API segment manufactures second generation anti-malaria APIs like quinine and salts as well as third generation anti-malarial products like Artemisinin-based salts. The company was founded by Kannan Kashi Vishwanathan on January 3, 2006 and is headquartered in Mumbai, India. | Health Technology |
